Behcet uveitis Anti tumor necrosis factor Behcet'
Conditions
Interventions
Patients that were diagnosed with Behcet'
s disease on the basis of the criteria proposed by the International Study Group for Behcet'
s disease and had related uveitis were included to the study group.
Treatment
Behcet uveitis
Sponsors
None
Eligibility
Sex/Gender
All
Age
19 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients that were diagnosed with Behcet's disease on the basis of the criteria proposed by the International Study Group for Behcet's disease and had related uveitis were included to the study group. Cases that were switched from conventional IMT to IFX therapy and had a minimum of 18 months of follow-up under IFX treatment were included to the study group
Exclusion criteria
Exclusion criteria: Cases attending irregular follow-ups and those with other retinal diseases were excluded from the study. Patients with a history of tuberculosis, active HBV-HCV-HIV and fungal infections were not included to the study. Patients with malignancy, liver, renal, cardiac or pulmonary insufficiency and diagnosis or suspicion of multiple sclerosis were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Control of ocular inflammation 1-3-6-12 and 24th months of the IFX treatment Standardization of Uveitis Nomenclature (SUN) Classification Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Extraocular manifestations of Behcet's disease At the 6 th month of treatment initiation Patient reported outcome using a questionnaire interview | — |
Countries
Turkey
Contacts
Public ContactOzgur Yalcinbayir
Uludag University
Outcome results
None listed